Crown Princess Mette-Marit of Norway Assessed for Lung Transplant amid 'Clear Worsening' of Health

On Dec. 19, the Royal House of Norway shared the health news about the wife of Crown Prince Haakon, who is the current heir ...

No gym or regular routine? Here’s how to stay fit over the holiday break

The festive season can throw our exercise routines out the window. You might be staying somewhere different, with no access ...

Insmed Impresses With Pulmonary Portfolio, But Still Lacks Remedy To Turn A Profit

Insmed is rated a hold, reflecting a robust therapeutic pipeline but persistent unprofitability, and is priced at a high ...

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Not intended for UK audiences Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2Affecting up to 100,000 people in ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
Hospital Healthcare Europe

Personalised rehabilitation for multimorbidity shows early promise

A personalised rehabilitation programme for adults with multiple long-term conditions is both acceptable and deliverable, ...